Welcome to PharmaSurgics |
Developing the first pharmaceutical-based treatment for adhesion preventionPost-surgical adhesions develop in millions of patients every year. They are a source of great patient suffering and enormous healthcare expenditure. PharmaSurgics is at the forefront of global development in the area of adhesion control. The company’s lead product (in Phase II development) represents the world’s first anti-adhesion treatment based on active pharmaceutical properties. It is expected to offer greater efficacy and improved ease of use. It also has the potential for use across a wide range of orthopedic and other surgical procedures. |
Adhesion Control
|
Post-surgical adhesions are bands of scar tissue connecting anatomic sites in the body that should not normally be connected. |
 |
Product Concept
|
Reduces inflammation & risk of infection. Unique formulation delivers greater efficacy. Safer and more easily applied than existing products. |
 |